WO2004054438A1 - Improvements in or relating to sensor devices for monitoring the condition of a human or animal patient - Google Patents

Improvements in or relating to sensor devices for monitoring the condition of a human or animal patient Download PDF

Info

Publication number
WO2004054438A1
WO2004054438A1 PCT/GB2003/005478 GB0305478W WO2004054438A1 WO 2004054438 A1 WO2004054438 A1 WO 2004054438A1 GB 0305478 W GB0305478 W GB 0305478W WO 2004054438 A1 WO2004054438 A1 WO 2004054438A1
Authority
WO
WIPO (PCT)
Prior art keywords
sensor device
sensor
mesh structure
filaments
mesh
Prior art date
Application number
PCT/GB2003/005478
Other languages
French (fr)
Inventor
William Paterson
Original Assignee
Diametrics Medical Limited
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Diametrics Medical Limited filed Critical Diametrics Medical Limited
Priority to AU2003288557A priority Critical patent/AU2003288557A1/en
Publication of WO2004054438A1 publication Critical patent/WO2004054438A1/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00Measuring for diagnostic purposes; Identification of persons
    • A61B5/145Measuring characteristics of blood in vivo, e.g. gas concentration, pH value; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid, cerebral tissue
    • A61B5/1455Measuring characteristics of blood in vivo, e.g. gas concentration, pH value; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid, cerebral tissue using optical sensors, e.g. spectral photometrical oximeters
    • A61B5/1459Measuring characteristics of blood in vivo, e.g. gas concentration, pH value; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid, cerebral tissue using optical sensors, e.g. spectral photometrical oximeters invasive, e.g. introduced into the body by a catheter
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00Measuring for diagnostic purposes; Identification of persons
    • A61B5/145Measuring characteristics of blood in vivo, e.g. gas concentration, pH value; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid, cerebral tissue
    • A61B5/14539Measuring characteristics of blood in vivo, e.g. gas concentration, pH value; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid, cerebral tissue for measuring pH
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00Measuring for diagnostic purposes; Identification of persons
    • A61B5/145Measuring characteristics of blood in vivo, e.g. gas concentration, pH value; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid, cerebral tissue
    • A61B5/14542Measuring characteristics of blood in vivo, e.g. gas concentration, pH value; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid, cerebral tissue for measuring blood gases
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00Measuring for diagnostic purposes; Identification of persons
    • A61B5/145Measuring characteristics of blood in vivo, e.g. gas concentration, pH value; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid, cerebral tissue
    • A61B5/1468Measuring characteristics of blood in vivo, e.g. gas concentration, pH value; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid, cerebral tissue using chemical or electrochemical methods, e.g. by polarographic means
    • A61B5/1473Measuring characteristics of blood in vivo, e.g. gas concentration, pH value; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid, cerebral tissue using chemical or electrochemical methods, e.g. by polarographic means invasive, e.g. introduced into the body by a catheter
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00Measuring for diagnostic purposes; Identification of persons
    • A61B5/68Arrangements of detecting, measuring or recording means, e.g. sensors, in relation to patient
    • A61B5/6846Arrangements of detecting, measuring or recording means, e.g. sensors, in relation to patient specially adapted to be brought in contact with an internal body part, i.e. invasive
    • A61B5/6867Arrangements of detecting, measuring or recording means, e.g. sensors, in relation to patient specially adapted to be brought in contact with an internal body part, i.e. invasive specially adapted to be attached or implanted in a specific body part
    • A61B5/6876Blood vessel
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00Measuring for diagnostic purposes; Identification of persons
    • A61B5/68Arrangements of detecting, measuring or recording means, e.g. sensors, in relation to patient
    • A61B5/6846Arrangements of detecting, measuring or recording means, e.g. sensors, in relation to patient specially adapted to be brought in contact with an internal body part, i.e. invasive
    • A61B5/6879Means for maintaining contact with the body
    • A61B5/6884Clamps or clips

Definitions

  • the invention relates to sensor devices for clinical use and in particular to sensor devices for monitoring the concentration of one or more analytes in human or animal patients .
  • a probe can be placed in the patient, for example in a blood vessel, in other bodily fluid or in tissue.
  • the probe may contain indicators, for example absorption and fluorescent indicators, which are arranged to provide data regarding certain analytes in the fluid or tissue, and to transmit that data to a base unit which in use of the sensor device is located outside the patient's body.
  • One such sensor device based on optical detection means, is known as the Paratrend Continuous Blood Gas Monitor available from Diametrics Medical Limited of High Wycombe, England, and can measure p0 2 , pC0 2 and pH .
  • Analyte concentrations in vivo can also be determined non-optically, for example, using electro-chemical sensors.
  • the probes may be exposed to unacceptable stresses, resulting in kinking, compression or breakage of the probe. Those stresses may arise on insertion of the probes, for example into muscle or other dense tissue, on usage, for example as a result of patient movement or muscle contraction at the site of use, or on withdrawal of the probe after use.
  • the invention provides a sensor device for use in a human or animal, comprising a probe within which there is located a sensor for an analyte, the sensor device comprising a mesh structure enveloping at least a portion of said probe.
  • the mesh structure is able to provide strength to the sensor structure whilst nonetheless offering good flexibility characteristics and permitting access of analytes to the probe and to the sensor or sensors therein. It is believed that the strength of the mesh-enveloped sensor device arises at least in part from the way in which a mesh structure spreads a locally applied load.
  • the mesh structure can eliminate the possibility of breakage of the sensor device on retraction.
  • Many mesh structures are, as a consequence of their structure, expansible. That can offer particular advantages in manufacture of the sensor devices in that the mesh structure can allow for a void of relatively large diameter to be adopted for insertion of parts during construction of the sensor whilst permitting a smaller diameter to be adopted thereafter in which the strengthening characteristics of the mesh structure are optimally utilised.
  • the mesh structure advantageously comprises a plurality of filaments, and preferably a multiplicity of filaments.
  • filaments is used herein to refer to any elongate strand irrespective of its cross-sectional configuration and structure, and includes for example strands of flat cross- sectional configuration which might be referred to as "strips" or "ribbons".
  • the filaments are strips of elongate cross-section.
  • the strips have a depth of not more than 100 ⁇ m, for example, from 5 to 100 ⁇ m, and preferably from 10 to 15 ⁇ m.
  • the strips have a width of not more than 50 ⁇ m.
  • the strips are of width from 5 ⁇ m to 50 ⁇ m .
  • the mesh structure comprises a plurality of helically wound filaments, at least a first said filament extending helically in the opposite sense to at least a second said filament.
  • the mesh structure comprises a first group of filaments, for example strips, extending in a first helical sense, and a second group of filaments, for example strips, extending in a second helical sense, opposed to the first.
  • the pitch between adjacent windings of each filament or, where there is a group of filaments, between adjacent filaments is so chosen that the open area not occupied by filaments is approximately from 0.3 to 0.7 cm 2 per cm 2 of the mesh structure, for example, about 0.5 cm 2 per cm 2 of the mesh structure in at least a region of the mesh structure in the vicinity of a sensor within the device.
  • the helical filament (s) extending in a first helical direction is/are interwoven with the helical filament (s) extending in a helical direction opposed to the first.
  • the mesh structure comprises a multiplicity of interwoven filaments.
  • the mesh structure comprises a knitted mesh.
  • first and second filaments may be joined to one another at points of overlap therebetween.
  • points of overlap between filaments are welded.
  • the mesh structure comprises filaments comprising a metallic material.
  • the filaments may comprise metallic ribbon.
  • the filaments comprise at least one metal selected from the group consisting of stainless steel, titanium and gold.
  • the filaments comprise a metallic core coated by a plastics material.
  • the mesh structure may comprise filaments of plastics material, for example, a synthetic polymer material selected from the group consisting of polyamides, polyesters, polyurethanes, polyolefins and fluoropolymers, for example, polytetrafluoroethylene (PTFE) .
  • plastics material for example, a synthetic polymer material selected from the group consisting of polyamides, polyesters, polyurethanes, polyolefins and fluoropolymers, for example, polytetrafluoroethylene (PTFE) .
  • PTFE polytetrafluoroethylene
  • points of contact between filaments are fixed, for example welded.
  • the mesh structure is constructed from monofilaments .
  • the mesh structure can be constructed of multifilament yarns.
  • the mesh structure is a braid.
  • the mesh structure defines an open area between adjacent filaments which constitutes at least 30% of the total surface area of the mesh (including the openings) . It is a simple matter for the skilled person to select an appropriate weave pattern and density for achieving a desired magnitude of open area, and taking account of the width of the filaments to be used.
  • the permeable material of the matrix extends at least partially into the openings. More preferably, the permeable material substantially fills the opening, whereby the mesh structure and the permeable material filling said openings define a substantially smooth outer surface of the sensor device.
  • the mesh structure is a mesh sleeve.
  • the external diameter of the mesh sleeve is from 0.5 to 1mm.
  • the mesh structure has a resistance to kinking and breakage which is such that the sensor device will not normally be subject to kinking or breakage when inserted into myocardial tissue and subjected to normal contractions thereof.
  • the mesh structure comprises first and second analyte sensors embedded in the matrix, the matrix being permeable to at least first and second analytes to be determined respectively by said first and second sensors.
  • the sensor device comprises a sensor for determining at least one parameter selected from p0 2f pC0 2 and pH.
  • the device comprises a first sensor for p0 2 , a second sensor for pC0 2 and a third sensor for pH.
  • the sensors are optical sensors.
  • first sensor comprising a chemical fluorescence indicator that is sensitive to oxygen
  • second sensor comprising a chemical absorption indicator that is sensitive to carbon dioxide
  • third sensor comprising a chemical absorption indicator that is sensitive to hydrogen ions.
  • the device further comprises a temperature measurement device, for example, a thermocouple.
  • the sensor device may be used in blood vessels for monitoring blood analytes or may be used in tissue, for example in muscular tissue or in organs.
  • the strength of the device makes it suitable for use even in muscles which can be subjected to strong contractions, including the myocardium, or in bodily fluids or tissues to which access can be obtained only through relatively dense tissue, for example, where the device is required to be sited in cerebrospinal fluid.
  • the mesh structure it is preferable for the mesh structure to be in the form of a sleeve.
  • the diameter of the sleeve may be reduced by applying tension to the sleeve in the axial direction.
  • the sensors which may comprise one or more analyte sensors and one or more sensors for physical parameters, for example, temperature
  • the tubes may be inserted through a proximal end of the tube whilst the tube diameter is relatively large, and tension may subsequently be applied axially to the tube so as to collapse it around the bundle of sensors.
  • the distal end of the mesh structure may then be closed, for example, with a polyethylene plug which may be heated to permit joining thereof to the mesh structure.
  • the void spaces within the mesh structure, including between the filaments of the mesh structure itself may then be filled by a filling material that is permeable to the analyte (s) to be determined, for example, by a hydrophilic gel.
  • hydrophilic gel there may be used any suitable hydrophilic gel that will permit the transport of hydrogen ions and the dissolved gases to be detected.
  • Suitable hydrogels include, for example, carboxymethylcellulose gels and, especially, polyacrylamide gels.
  • the use of hydrogels, in particular, polyacrylamide gels, as a matrix in blood gas sensors is known and the gels can be incorporated in the sensor devices of the present invention by means analogous to those known and used for the manufacture of the known sensor devices.
  • the mesh sleeve is arranged to have an external diameter of 0.5 to 1 mm in the sensor device, and to have an expanded external diameter of exceeding 1 mm, for example, of at least 1.5 mm.
  • the invention also provides a method of making a sensor device, comprising maintaining a mesh sleeve in a first, expanded, configuration, inserting one or more sensors into the mesh sleeve in said expanded configuration, causing the mesh sleeve to adopt a second, contracted configuration in which it has a smaller internal diameter than in the first configuration, and closing at least a distal end of the mesh sleeve to enclose the sensor (s) .
  • the mesh structure and enclosed sensor (s) are subjected to a treatment in which a gel is formed in void regions, inside the mesh sleeve and in open regions of the sleeve itself.
  • the invention further provides a method of monitoring myocardial tissue, comprising inserting into the myocardium of a patient a flexible sensor probe comprising a housing and a sensor therein for at least one analyte and monitoring the at least one analyte.
  • at least one analyte comprises one or more blood gases.
  • the concentration of blood gases and especially oxygen in myocardial tissue provides valuable information regarding the efficiency of myocardial perfusion and may be particularly advantageous during cardiac or coronary surgery and post-operatively when it can give early warning of the failure of perfusion or of the failure successfully to reperfuse following surgery.
  • Fig. 1 is a perspective view of a probe of a sensor device according to the invention
  • Fig. 2 is a longitudinal section through an end portion of the probe.
  • Fig. 3 is a transverse section through an end portion of the probe.
  • a sensor. device 1 has a probe which is suitable for insertion into a blood vessel or into tissue.
  • the probe has a matrix 2 of a hydrophilic gel, for example, a polyacrylamide gel.
  • Embedded in the matrix 2 are a first optical sensor 3 for determining oxygen partial pressure (p0 2 ) , a second sensor 4 for determining carbon dioxide partial pressure (pC0 2 ) , and a third sensor 5 for determining pH.
  • the matrix 2 is permeable to hydrogen ions and to oxygen and carbon dioxide.
  • the matrix 2 is partially enveloped by mesh structure 6, which is made up of two groups 7, 8 of helically wound metal ribbons.
  • a first group 7 of said helically extending metal ribbons has three equally spaced ribbons 7 1 , 7 11 and 7 1U .
  • the second group 8 of ribbons has three equally spaced ribbons 8 1 , 8 11 and 8 111 .
  • Each ribbon 7 1 , 7 11 and 7 U1 alternately overlies and underlies the ribbons of group 8 at points of overlap so as to form an essentially woven sleeve.
  • the groups 7, 8 of filaments define a mesh structure having openings 9, each of which has a diameter of about 0.7mm. (The diameter in relation to the openings, when not circular, is to be taken to be the largest distance between two separate points on the perimeter of the opening) .
  • the openings 9 are filled with hydrophilic gel, which is integral with the rest of the matrix 2.
  • the ribbons of group 7 overlie or underlie the ribbons of group 8 at points of overlap 10.
  • the ribbons may, if desired, be welded together at the points 10, but are not welded in the embodiment shown.
  • Fig. 3 is a transverse section through the embodiment of Figs. 1 and 2.
  • the probe can be inserted into a blood vessel in known manner through a catheter. It can also be inserted into soft tissue, for example, into muscular tissue or an organ. It may be introduced using a needle, for example, of the kind disclosed in WO 01/78588.
  • the mesh imparts strength to the sensor device, and enhances resistance to kinking. It can also prevent disintegration of the probe when the probe is retracted from the patient, and provides support to the sensor device on insertion. Moreover, when the sensor device is used in regions m which it will be sub ected to significant stresses, the mesh structure can prevent kinking and breakage. By way of example, the mesh structure may prevent damage resulting from movement of the patient.
  • the sensor device of the invention will offer advantages when used to monitor myocardial function, where the probe may be subjected to severe stresses as a result of the strong systolic contraction of the myocardium.
  • the probe, and the sensor within it are positioned within the body of the patient. That allows monitoring of an analyte or analytes to take place m situ within the body, for example continuously, without withdrawal from the body of fluid to be analysed, although it will be appreciated that the additional withdrawal of fluid samples, though the probe or otherwise, for analysis is not excluded.

Abstract

A sensor device (1) for use in a human or animal comprises a probe within which there is located a sensor (3, 4) for an analyte. For providing improved strength, the sensor device comprises a mesh structure (6) enveloping at least a portion of the probe.

Description

Improvements in or relating to sensor devices for monitoring the condition of a human or animal patient
The invention relates to sensor devices for clinical use and in particular to sensor devices for monitoring the concentration of one or more analytes in human or animal patients .
The measurement in blood or other bodily fluids of certain analytes, for example, dissolved oxygen, carbon dioxide and hydrogen ions (which may be expressed as partial pressure of oxygen and carbon dioxide, (referred to hereafter as p02 and pC02 respectively) and as pH) , can be important during surgery, post-operatively and during hospitalisation under intensive care. In certain known forms of sensor device, a probe can be placed in the patient, for example in a blood vessel, in other bodily fluid or in tissue. The probe may contain indicators, for example absorption and fluorescent indicators, which are arranged to provide data regarding certain analytes in the fluid or tissue, and to transmit that data to a base unit which in use of the sensor device is located outside the patient's body. One such sensor device, based on optical detection means, is known as the Paratrend Continuous Blood Gas Monitor available from Diametrics Medical Limited of High Wycombe, England, and can measure p02, pC02 and pH . Analyte concentrations in vivo can also be determined non-optically, for example, using electro-chemical sensors.
In certain circumstances, and in particular where fine and/or delicate probes are used in tissue or in cerebrospinal fluid, the probes may be exposed to unacceptable stresses, resulting in kinking, compression or breakage of the probe. Those stresses may arise on insertion of the probes, for example into muscle or other dense tissue, on usage, for example as a result of patient movement or muscle contraction at the site of use, or on withdrawal of the probe after use.
Accordingly, there is a need for sensor devices which have sufficient strength to withstand more effectively the stresses to which they will be subjected in use. The invention provides a sensor device for use in a human or animal, comprising a probe within which there is located a sensor for an analyte, the sensor device comprising a mesh structure enveloping at least a portion of said probe. The mesh structure is able to provide strength to the sensor structure whilst nonetheless offering good flexibility characteristics and permitting access of analytes to the probe and to the sensor or sensors therein. It is believed that the strength of the mesh-enveloped sensor device arises at least in part from the way in which a mesh structure spreads a locally applied load. Furthermore, the mesh structure can eliminate the possibility of breakage of the sensor device on retraction. Many mesh structures are, as a consequence of their structure, expansible. That can offer particular advantages in manufacture of the sensor devices in that the mesh structure can allow for a void of relatively large diameter to be adopted for insertion of parts during construction of the sensor whilst permitting a smaller diameter to be adopted thereafter in which the strengthening characteristics of the mesh structure are optimally utilised.
The mesh structure advantageously comprises a plurality of filaments, and preferably a multiplicity of filaments. The term "filaments" is used herein to refer to any elongate strand irrespective of its cross-sectional configuration and structure, and includes for example strands of flat cross- sectional configuration which might be referred to as "strips" or "ribbons". Advantageously, the filaments are strips of elongate cross-section. Advantageously, the strips have a depth of not more than 100 μm, for example, from 5 to 100 μm, and preferably from 10 to 15 μm. Advantageously, the strips have a width of not more than 50 μm. Advantageously, the strips are of width from 5 μm to 50 μm .
Advantageously, the mesh structure comprises a plurality of helically wound filaments, at least a first said filament extending helically in the opposite sense to at least a second said filament. Preferably, the mesh structure comprises a first group of filaments, for example strips, extending in a first helical sense, and a second group of filaments, for example strips, extending in a second helical sense, opposed to the first. The pitch between adjacent windings of each filament or, where there is a group of filaments, between adjacent filaments is so chosen that the open area not occupied by filaments is approximately from 0.3 to 0.7 cm2 per cm2 of the mesh structure, for example, about 0.5 cm2 per cm2 of the mesh structure in at least a region of the mesh structure in the vicinity of a sensor within the device. Preferably, the helical filament (s) extending in a first helical direction is/are interwoven with the helical filament (s) extending in a helical direction opposed to the first. Preferably, the mesh structure comprises a multiplicity of interwoven filaments. In another form of device, the mesh structure comprises a knitted mesh.
In some circumstances, first and second filaments may be joined to one another at points of overlap therebetween. Advantageously, points of overlap between filaments are welded. Although attachment of the filaments at points of overlap may reduce the flexibility of the sensor device, it may improve the dimensional stability of the mesh structure and thus of the sensor device, providing increased strength in use.
Advantageously, the mesh structure comprises filaments comprising a metallic material. For example, the filaments may comprise metallic ribbon. Advantageously, the filaments comprise at least one metal selected from the group consisting of stainless steel, titanium and gold. Preferably, the filaments comprise a metallic core coated by a plastics material.
The mesh structure may comprise filaments of plastics material, for example, a synthetic polymer material selected from the group consisting of polyamides, polyesters, polyurethanes, polyolefins and fluoropolymers, for example, polytetrafluoroethylene (PTFE) .
Advantageously, points of contact between filaments are fixed, for example welded.
Advantageously, the mesh structure is constructed from monofilaments . If desired, the mesh structure can be constructed of multifilament yarns. Preferably, the mesh structure is a braid. Advantageously, the mesh structure defines an open area between adjacent filaments which constitutes at least 30% of the total surface area of the mesh (including the openings) . It is a simple matter for the skilled person to select an appropriate weave pattern and density for achieving a desired magnitude of open area, and taking account of the width of the filaments to be used.
Preferably, the permeable material of the matrix extends at least partially into the openings. More preferably, the permeable material substantially fills the opening, whereby the mesh structure and the permeable material filling said openings define a substantially smooth outer surface of the sensor device.
Preferably, the mesh structure is a mesh sleeve. Advantageously, the external diameter of the mesh sleeve is from 0.5 to 1mm.
Preferably, the mesh structure has a resistance to kinking and breakage which is such that the sensor device will not normally be subject to kinking or breakage when inserted into myocardial tissue and subjected to normal contractions thereof.
Advantageously, the mesh structure comprises first and second analyte sensors embedded in the matrix, the matrix being permeable to at least first and second analytes to be determined respectively by said first and second sensors. Advantageously, the sensor device comprises a sensor for determining at least one parameter selected from p02f pC02 and pH. Preferably, the device comprises a first sensor for p02, a second sensor for pC02 and a third sensor for pH. Advantageously, the sensors are optical sensors. In a particularly advantageous embodiment, there is a first sensor comprising a chemical fluorescence indicator that is sensitive to oxygen, a second sensor comprising a chemical absorption indicator that is sensitive to carbon dioxide, and a third sensor comprising a chemical absorption indicator that is sensitive to hydrogen ions.
Advantageously, the device further comprises a temperature measurement device, for example, a thermocouple. The sensor device may be used in blood vessels for monitoring blood analytes or may be used in tissue, for example in muscular tissue or in organs. The strength of the device makes it suitable for use even in muscles which can be subjected to strong contractions, including the myocardium, or in bodily fluids or tissues to which access can be obtained only through relatively dense tissue, for example, where the device is required to be sited in cerebrospinal fluid. As already mentioned, it is preferable for the mesh structure to be in the form of a sleeve. Preferably, the diameter of the sleeve may be reduced by applying tension to the sleeve in the axial direction. Such structures offer particular advantages in manufacture of the sensor device in that the sensors, which may comprise one or more analyte sensors and one or more sensors for physical parameters, for example, temperature, may be inserted through a proximal end of the tube whilst the tube diameter is relatively large, and tension may subsequently be applied axially to the tube so as to collapse it around the bundle of sensors. The distal end of the mesh structure may then be closed, for example, with a polyethylene plug which may be heated to permit joining thereof to the mesh structure. The void spaces within the mesh structure, including between the filaments of the mesh structure itself may then be filled by a filling material that is permeable to the analyte (s) to be determined, for example, by a hydrophilic gel. As hydrophilic gel there may be used any suitable hydrophilic gel that will permit the transport of hydrogen ions and the dissolved gases to be detected. Suitable hydrogels include, for example, carboxymethylcellulose gels and, especially, polyacrylamide gels. The use of hydrogels, in particular, polyacrylamide gels, as a matrix in blood gas sensors is known and the gels can be incorporated in the sensor devices of the present invention by means analogous to those known and used for the manufacture of the known sensor devices.
Advantageously, the mesh sleeve is arranged to have an external diameter of 0.5 to 1 mm in the sensor device, and to have an expanded external diameter of exceeding 1 mm, for example, of at least 1.5 mm.
Thus, the invention also provides a method of making a sensor device, comprising maintaining a mesh sleeve in a first, expanded, configuration, inserting one or more sensors into the mesh sleeve in said expanded configuration, causing the mesh sleeve to adopt a second, contracted configuration in which it has a smaller internal diameter than in the first configuration, and closing at least a distal end of the mesh sleeve to enclose the sensor (s) .
Preferably, the mesh structure and enclosed sensor (s) are subjected to a treatment in which a gel is formed in void regions, inside the mesh sleeve and in open regions of the sleeve itself. The invention further provides a method of monitoring myocardial tissue, comprising inserting into the myocardium of a patient a flexible sensor probe comprising a housing and a sensor therein for at least one analyte and monitoring the at least one analyte. Advantageously, at least one analyte comprises one or more blood gases. The concentration of blood gases and especially oxygen in myocardial tissue provides valuable information regarding the efficiency of myocardial perfusion and may be particularly advantageous during cardiac or coronary surgery and post-operatively when it can give early warning of the failure of perfusion or of the failure successfully to reperfuse following surgery.
The use of rigid sensors in the myocardium is known in, for example, the Khuri myocardial pH monitoring system made by Terumo Cardiovascular Systems Corporation of Tustin California and in a device described in Clinical Science (2000) 98, 321-328 ("Myocardial tissue oxygen supply and utilisation during coronary artery bypass surgery: evidence of microvascular no-reflow") . In contrast to the rigid structures described in those prior disclosures, however, the method of the present invention in which a flexible sensor probe is used provides for greater selectivity in the siting of the sensor probe within the myocardium, in some cases possibly also reducing the disruption and/or damage to immediately surrounding tissue. In the method of the invention any suitable form of sensor (s) may be used. Advantageously, however, there is present in the probe one or more analyte sensors which are optical sensors. Certain illustrative embodiments of the invention will now be described in detail with reference to the accompanying drawings, in which:
Fig. 1 is a perspective view of a probe of a sensor device according to the invention;
Fig. 2 is a longitudinal section through an end portion of the probe; and
Fig. 3 is a transverse section through an end portion of the probe. With reference to Fig. 1, a sensor. device 1 has a probe which is suitable for insertion into a blood vessel or into tissue. The probe has a matrix 2 of a hydrophilic gel, for example, a polyacrylamide gel. Embedded in the matrix 2 are a first optical sensor 3 for determining oxygen partial pressure (p02) , a second sensor 4 for determining carbon dioxide partial pressure (pC02) , and a third sensor 5 for determining pH. The matrix 2 is permeable to hydrogen ions and to oxygen and carbon dioxide. The matrix 2 is partially enveloped by mesh structure 6, which is made up of two groups 7, 8 of helically wound metal ribbons. A first group 7 of said helically extending metal ribbons has three equally spaced ribbons 71, 711 and 71U. The second group 8 of ribbons has three equally spaced ribbons 81, 811 and 8111. Each ribbon 71, 711 and 7U1 alternately overlies and underlies the ribbons of group 8 at points of overlap so as to form an essentially woven sleeve. The groups 7, 8 of filaments define a mesh structure having openings 9, each of which has a diameter of about 0.7mm. (The diameter in relation to the openings, when not circular, is to be taken to be the largest distance between two separate points on the perimeter of the opening) .
The openings 9 are filled with hydrophilic gel, which is integral with the rest of the matrix 2. Referring to Fig. 2, the ribbons of group 7 overlie or underlie the ribbons of group 8 at points of overlap 10. The ribbons may, if desired, be welded together at the points 10, but are not welded in the embodiment shown.
Fig. 3 is a transverse section through the embodiment of Figs. 1 and 2.
The probe can be inserted into a blood vessel in known manner through a catheter. It can also be inserted into soft tissue, for example, into muscular tissue or an organ. It may be introduced using a needle, for example, of the kind disclosed in WO 01/78588. The mesh imparts strength to the sensor device, and enhances resistance to kinking. It can also prevent disintegration of the probe when the probe is retracted from the patient, and provides support to the sensor device on insertion. Moreover, when the sensor device is used in regions m which it will be sub ected to significant stresses, the mesh structure can prevent kinking and breakage. By way of example, the mesh structure may prevent damage resulting from movement of the patient. It is in particular envisaged that the sensor device of the invention will offer advantages when used to monitor myocardial function, where the probe may be subjected to severe stresses as a result of the strong systolic contraction of the myocardium. In accordance with the invention, there is at least one sensor located within the probe. In use of the device of the invention, the probe, and the sensor within it, are positioned within the body of the patient. That allows monitoring of an analyte or analytes to take place m situ within the body, for example continuously, without withdrawal from the body of fluid to be analysed, although it will be appreciated that the additional withdrawal of fluid samples, though the probe or otherwise, for analysis is not excluded.

Claims

Cla ims
1. A sensor device for use in a human or animal, comprising a probe within which there is located a sensor for an analyte, the sensor device comprising a mesh structure enveloping at least a portion of said probe.
2. A sensor device according to claim 1, in which the mesh structure comprises a plurality of filaments.
3. A sensor device according to claim 2, in which the mesh structure comprises a multiplicity of filaments.
4. A sensor device according to any one of the preceding claims, in which the filaments are strips of elongate cross- section .
5. A sensor device according to claim 4, in which the strips are of width from 5 μm to 50 μm.
6. A sensor device according to claim 4, in which the strips are of depth from 5 μm to 50 μm.
7. A sensor device according to any one of the preceding claims in which the mesh structure defines an open area of at. least 0.3 cm2 per cm2 of the mesh structure.
8. A sensor device according to any one of the preceding claims, in which the mesh structure defines an open area of not more than 0.7 cm2 per cm2 of the mesh structure.
9. A sensor device according to any one of the preceding claims, in which the mesh structure comprises a plurality of helically wound filaments, at least a first said filament extending helically in the opposite sense to at least a second said filament.
10. A sensor device according to any one of the preceding claims, in which the mesh structure is a woven mesh structure .
11. A sensor device according to any one of the preceding claims, in which the mesh structure comprises a multiplicity of interwoven filaments.
12. A sensor device according to any one of the preceding claims, in which first and second filaments are joined to one another at points of overlap therebetween.
13. A sensor device according to any one of the preceding claims, in which the mesh structure comprises filaments comprising a metallic material.
14. A sensor device according to claim 13, in which the filaments comprise metallic ribbon.
15. A sensor device according to claim 13 or claim 14, in which the filaments comprise at least one metal selected from the group consisting of stainless steel, titanium and gold.
16. A sensor device according to any one of claims 13 to 15, in which the filaments comprise a metallic core coated by a plastics material.
17. A sensor device according to any one of the preceding claims, in which the mesh structure comprises filaments of plastics material.
18. A sensor device according to claim 14, in which the filaments comprise a synthetic polymer material selected from the group consisting of polyamides, polyesters, polyurethanes, polyolefins and fluoropolymers .
19. A sensor device according to any one of the preceding claims in which points of overlap between filaments are welded.
20. A sensor device according to any one of the preceding claims, in which the mesh structure is constructed from monofilaments .
21. A sensor device according to any one of claims 1 to 19, in which the mesh structure is constructed of multifilament yarns .
22. A sensor device according to any one of the preceding claims, in which the mesh structure is a braid.
23. A sensor device according to any one of the preceding claims, in which the probe comprises a matrix of a permeable material, and the sensor is located within the matrix.
24. A sensor device according to claim 23, in which the mesh defines openings, and the permeable material of the matrix extends at least partially into the openings .
25. A sensor device according to claim 24, in which the permeable material substantially fills the opening, whereby the mesh structure and the permeable material filling said openings form a substantially smooth outer surface of the sensor device.
26. A sensor device according to any one of the preceding claims, in which the mesh structure is a mesh sleeve.
27. A sensor device according to claim 26, in which the external diameter of the mesh sleeve is from 0.5 to 1mm.
28. A sensor device according to any one of the preceding claims, in which the probe comprises first and second analyte sensors embedded in a matrix, the matrix being permeable to at least first and second analytes to be determined respectively by said first and second sensors.
29. A sensor device according to any one of the preceding claims, comprising a sensor for determining at least one parameter selected from p02, pC02 and pH .
30. A sensor device according to claim 30, comprising a first sensor for p02, a second sensor for pC02 and a third sensor for pH .
31. A sensor device according to any one of the preceding claims, which further comprises a temperature measurement device .
32. A sensor device substantially as described herein with reference to and as illustrated by any one of Figs. 1 to 3.
33. A method of making a sensor device comprising maintaining a mesh sleeve in a first, expanded, configuration, inserting one or more sensors into the mesh sleeve in said expanded configuration, causing the mesh sleeve to adapt a second, contracted configuration in which it has a smaller internal diameter than in the first configuration, and closing at least a distal end of the mesh sleeve to enclose the sensor(s).
34. A method of monitoring myocardial tissue, comprising inserting into the myocardium of a patient a flexible sensor probe comprising a housing and a sensor therein for at least one analyte.
35. A method according to claim 34, in which the sensor probe comprises one or more optical sensors.
36. A method according to claim 34, in which the sensor probe is inserted before or during cardiac or coronary surgery to monitor blood gas perfusion during surgery.
37. A method according to claim 34, in which the sensor is inserted before, during or after cardiac or coronary surgery to monitor myocardial reperfusion post-operatively .
PCT/GB2003/005478 2002-12-16 2003-12-16 Improvements in or relating to sensor devices for monitoring the condition of a human or animal patient WO2004054438A1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
AU2003288557A AU2003288557A1 (en) 2002-12-16 2003-12-16 Improvements in or relating to sensor devices for monitoring the condition of a human or animal patient

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB0229263.9 2002-12-16
GB0229263A GB0229263D0 (en) 2002-12-16 2002-12-16 Improvements in or relating to sensor devices for monitoring the condition of a human or animal patient

Publications (1)

Publication Number Publication Date
WO2004054438A1 true WO2004054438A1 (en) 2004-07-01

Family

ID=9949755

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/GB2003/005478 WO2004054438A1 (en) 2002-12-16 2003-12-16 Improvements in or relating to sensor devices for monitoring the condition of a human or animal patient

Country Status (3)

Country Link
AU (1) AU2003288557A1 (en)
GB (1) GB0229263D0 (en)
WO (1) WO2004054438A1 (en)

Cited By (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2009019470A1 (en) * 2007-08-09 2009-02-12 Glysure Ltd Sensing apparatus
US8473222B2 (en) 2010-03-11 2013-06-25 Glumetrics, Inc. Measurement devices and methods for measuring analyte concentration incorporating temperature and pH correction
US8838195B2 (en) 2007-02-06 2014-09-16 Medtronic Minimed, Inc. Optical systems and methods for ratiometric measurement of blood glucose concentration
US8979790B2 (en) 2007-11-21 2015-03-17 Medtronic Minimed, Inc. Use of an equilibrium sensor to monitor glucose concentration
DE102012201390B4 (en) 2012-01-24 2017-03-30 Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung e.V. Sensor arrangement for a vacuum therapy system and vacuum therapy system with sensor functionality
WO2021175531A1 (en) * 2020-03-05 2021-09-10 Sensocure As Membrane sealing for a physiological sensor

Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2030454A (en) * 1978-09-22 1980-04-10 Delpy D T Improved instruments for use in the measurement of gases in body fluids
US5673235A (en) * 1987-07-30 1997-09-30 The United States Of America As Represented By The Secretary Of The Navy Sock shaped internal strength member for towed arrays
US5967986A (en) * 1997-11-25 1999-10-19 Vascusense, Inc. Endoluminal implant with fluid flow sensing capability
US6023630A (en) * 1996-02-12 2000-02-08 Electrolux S.A.R.L. Probe assembly and apparatus for measuring the PH of a tissue of a human or animal organ
US20020128546A1 (en) * 2000-05-15 2002-09-12 Silver James H. Implantable sensor
US6470199B1 (en) * 2000-06-21 2002-10-22 Masimo Corporation Elastic sock for positioning an optical probe

Patent Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2030454A (en) * 1978-09-22 1980-04-10 Delpy D T Improved instruments for use in the measurement of gases in body fluids
US5673235A (en) * 1987-07-30 1997-09-30 The United States Of America As Represented By The Secretary Of The Navy Sock shaped internal strength member for towed arrays
US6023630A (en) * 1996-02-12 2000-02-08 Electrolux S.A.R.L. Probe assembly and apparatus for measuring the PH of a tissue of a human or animal organ
US5967986A (en) * 1997-11-25 1999-10-19 Vascusense, Inc. Endoluminal implant with fluid flow sensing capability
US20020128546A1 (en) * 2000-05-15 2002-09-12 Silver James H. Implantable sensor
US6470199B1 (en) * 2000-06-21 2002-10-22 Masimo Corporation Elastic sock for positioning an optical probe

Cited By (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8838195B2 (en) 2007-02-06 2014-09-16 Medtronic Minimed, Inc. Optical systems and methods for ratiometric measurement of blood glucose concentration
US9839378B2 (en) 2007-02-06 2017-12-12 Medtronic Minimed, Inc. Optical systems and methods for ratiometric measurement of blood glucose concentration
WO2009019470A1 (en) * 2007-08-09 2009-02-12 Glysure Ltd Sensing apparatus
US8979790B2 (en) 2007-11-21 2015-03-17 Medtronic Minimed, Inc. Use of an equilibrium sensor to monitor glucose concentration
US8473222B2 (en) 2010-03-11 2013-06-25 Glumetrics, Inc. Measurement devices and methods for measuring analyte concentration incorporating temperature and pH correction
DE102012201390B4 (en) 2012-01-24 2017-03-30 Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung e.V. Sensor arrangement for a vacuum therapy system and vacuum therapy system with sensor functionality
WO2021175531A1 (en) * 2020-03-05 2021-09-10 Sensocure As Membrane sealing for a physiological sensor
AU2021229517B2 (en) * 2020-03-05 2023-10-26 Sensocure As Membrane sealing for a physiological sensor

Also Published As

Publication number Publication date
AU2003288557A1 (en) 2004-07-09
GB0229263D0 (en) 2003-01-22

Similar Documents

Publication Publication Date Title
US5788631A (en) Hollow viscus and solid organ tonometry
JP2010535561A (en) Sensing device
JP2739880B2 (en) Measurement of bladder oxygen
US9492113B2 (en) Systems and methods for monitoring organ activity
CA2580572C (en) Bowel management system with physiologic sensors
JP4741470B2 (en) Medical instruments
US20100252430A1 (en) Sensor for measuring a bioanalyte such as lactate
EP1709924A1 (en) Ablation catheter
WO2005096991A1 (en) Ureteric stents
US5526809A (en) Hollow viscous and soild organ tonometry
CN102139136A (en) Sacculus dilatation catheter
US20060178571A1 (en) Apparatus and method for determining organ perfusion
WO2004054438A1 (en) Improvements in or relating to sensor devices for monitoring the condition of a human or animal patient
CA1241584A (en) Hollow viscus tonometry
US20040167426A1 (en) Method and device for locating visceral constrictions
CN217390710U (en) Probe for measuring physiological signals
CA1335709C (en) Hollow viscus and solid organ tonometry
WO2004058057A1 (en) Sensor device for monitoring perfusion of tissue
JPH05337191A (en) Lead-in catheter and using method of the same to support probe in blood vessel
CA3166340A1 (en) Membrane sealing for a physiological sensor
DE102012012180A1 (en) Device for in-vivo measurement of oxygen partial pressure of intravascular fluid, has polarographic measurement unit for oxygen partial pressure measurement, which is arranged along catheter
Weil et al. Patient CO2 measurement
JP2004201793A (en) Chemical testing device

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A1

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BW BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE EG ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NI NO NZ OM PG PH PL PT RO RU SC SD SE SG SK SL SY TJ TM TN TR TT TZ UA UG US UZ VC VN YU ZA ZM ZW

AL Designated countries for regional patents

Kind code of ref document: A1

Designated state(s): BW GH GM KE LS MW MZ SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LU MC NL PT RO SE SI SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
32PN Ep: public notification in the ep bulletin as address of the adressee cannot be established

Free format text: NOTING OF LOSS OF RIGHTS PURSUANT TO RULE 69(1) EPC. (EPO FORM 1205A DATED 23.08.2005)

122 Ep: pct application non-entry in european phase
NENP Non-entry into the national phase

Ref country code: JP

WWW Wipo information: withdrawn in national office

Country of ref document: JP